TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33019950

Group type: EXPERIMENTAL
Intervention: Traffic Light Labelling (TLL)
Number of subjects: 1997

Group type: EXPERIMENTAL
Intervention: Health Star Ratings (HSR)
Number of subjects: 1997

Group type: EXPERIMENTAL
Intervention: 'High in' Warning Labels (WL)
Number of subjects: 1997

Group type: COMPARATOR
Intervention: Control (no interpretive FOP labelling)
Number of subjects: 1997

Group type: EXPERIMENTAL
Intervention: All FOP labelling systems
Number of subjects: 1997
Study: 32720832

Group type: EXPERIMENTAL
Intervention: Probiotics (Bifidobacterium lactis Bi‐07, Lactobacillus rhamnosus HN001, Lactobacillus acidophilus NCFM) with conventional treatment
Number of subjects: 194

Group type: COMPARATOR
Intervention: Conventional treatment without probiotics
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Probiotics with conventional treatment
Number of subjects: 194
Study: 35307306

Group type: EXPERIMENTAL
Intervention: APPv treatment
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: APPv-urologist agreement
Number of subjects: 100
Study: 32959587

Group type: EXPERIMENTAL
Intervention: Fu's subcutaneous needling
Number of subjects: 30

Group type: COMPARATOR
Intervention: Simple resistance training (Control)
Number of subjects: 30
Study: 34898061

Group type: EXPERIMENTAL
Intervention: Bleaching+Tannic acid+Doulink
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bleaching+Quercetin+Doulink
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bleaching+Panavia SA
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bleaching+Tannic acid+Panavia SA
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bleaching+Quercetin+Panavia SA
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control/Doulink
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control/PSA
Number of subjects: 80
Study: 32006264

Group type: EXPERIMENTAL
Intervention: CO2 laser irradiation (20 Hz, 1 W, 30 s)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Remin Pro paste
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: CO2 laser followed by Remin Pro application (group 2)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 78
Study: 36443214

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 33
Study: 33135321

Group type: EXPERIMENTAL
Intervention: Children of CNS tumor survivors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Boys of CNS tumor survivors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matched comparisons (control group)
Number of subjects: 0
Study: 32251139

Group type: EXPERIMENTAL
Intervention: Educational pamphlets
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Educational pamphlets plus text messages
Number of subjects: 563

Group type: COMPARATOR
Intervention: No education
Number of subjects: 563
Study: 36057375

Group type: EXPERIMENTAL
Intervention: Building Better Caregivers (BBC) workshop
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 0
Study: 33630140

Group type: EXPERIMENTAL
Intervention: Opicapone 50 mg
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Opicapone 25 mg
Number of subjects: 391

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 391
Study: 32732928

Group type: EXPERIMENTAL
Intervention: RCA‐ALSS therapy with R‐CA model
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: RCA‐ALSS therapy with R‐CA score
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: RCA‐ALSS therapy with R‐CA score of 0-2
Number of subjects: 338
Study: 35050203

Group type: EXPERIMENTAL
Intervention: Scaled to body weight high-fat meal (9 kcal/kg; 70% fat)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standardized high-fat meal containing 75 g of fat (70% fat)
Number of subjects: 16
Study: 32236212

Group type: EXPERIMENTAL
Intervention: Cocoa supplementation (5 g daily, 425 mg of flavanols)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34052070

Group type: EXPERIMENTAL
Intervention: Amniotic membrane (AM) patches
Number of subjects: 50

Group type: COMPARATOR
Intervention: Biological substitutes
Number of subjects: 50
Study: 32484533

Group type: EXPERIMENTAL
Intervention: Tablet-based decision support tool prior to 25 weeks' gestation
Number of subjects: 1485

Group type: COMPARATOR
Intervention: Usual care (without the tool)
Number of subjects: 1485
Study: 35737696

Group type: EXPERIMENTAL
Intervention: Intense pulsed light (IPL) + Meibomian gland expression (MGX)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham + Meibomian gland expression (MGX)
Number of subjects: 100
Study: 34076601

Group type: EXPERIMENTAL
Intervention: Oral ASA 300 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Intravenous lysine acetylsalicylate 150 mg
Number of subjects: 23
Study: 32326177

Group type: EXPERIMENTAL
Intervention: Targeted protein‐fortified human milk (HM)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard fortified human milk (HM)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Targeted protein‐fortified human milk (HM) with at least 30 intervention days
Number of subjects: 36
Study: 33998374

Group type: EXPERIMENTAL
Intervention: Basic photography training (20 hours theoretical and 30 hours practice over 8 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 20
Study: 33582692

Group type: EXPERIMENTAL
Intervention: Caudal block with 2 mg/kg Bupivacaine mixed with 0.75 mcg/kg Dexmedetomidine (Group B)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Caudal block with 2 mg/kg Bupivacaine (Group A)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study: 32914876

Group type: EXPERIMENTAL
Intervention: High BMI
Number of subjects: 29266

Group type: EXPERIMENTAL
Intervention: High BMI (after adjustment for smoking behaviors)
Number of subjects: 29266

Group type: EXPERIMENTAL
Intervention: High BMI (UVMR analysis)
Number of subjects: 29266

Group type: EXPERIMENTAL
Intervention: High BMI (after adjustment for smoking)
Number of subjects: 29266
Study: 32526634

Group type: EXPERIMENTAL
Intervention: Panitumumab plus irinotecan
Number of subjects: 121

Group type: COMPARATOR
Intervention: Cetuximab plus irinotecan
Number of subjects: 121
Study: 35110315

Group type: EXPERIMENTAL
Intervention: 20 mg/kg TXA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33970268

Group type: EXPERIMENTAL
Intervention: Multidomain intervention (diet, exercise, cognitive training, and vascular risk management)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (general health advice)
Number of subjects: 112
Study: 35856942

Group type: EXPERIMENTAL
Intervention: Endovascular recanalization
Number of subjects: 224
Study: 34680728

Group type: EXPERIMENTAL
Intervention: Pharmacist-led educational intervention
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual care with no intervention
Number of subjects: 400
Study: 35854106

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid supplementation (300 mg once a day for 8 weeks)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo (once a day for 8 weeks)
Number of subjects: 124
Study: 32763623

Group type: EXPERIMENTAL
Intervention: Progesterone (200 mg twice per day)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 32949071

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D levels
Number of subjects: 0
Study: 33308329

Group type: EXPERIMENTAL
Intervention: Prompt provision of clozapine for patients with treatment-resistant schizophrenia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Universal provision of cognitive-behavioural therapy for patients at clinical high risk of psychosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Universal provision of family intervention for patients with first-episode psychosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Full adherence to the NICE guideline recommendations
Number of subjects: 0
Study: 35226357

Group type: EXPERIMENTAL
Intervention: OSNA assay
Number of subjects: 4757
Study: 32218418

Group type: EXPERIMENTAL
Intervention: Liver cirrhosis patients
Number of subjects: 81

Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 81
Study: 32772857

Group type: EXPERIMENTAL
Intervention: Behavioral lifestyle intervention
Number of subjects: 33

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 33
Study: 32473149

Group type: EXPERIMENTAL
Intervention: Height for age z scores (HAZ) in the first two years of life
Number of subjects: 791

Group type: EXPERIMENTAL
Intervention: Change in HAZ scores between early and later childhood
Number of subjects: 791
Study: 34081217

Group type: EXPERIMENTAL
Intervention: Mavacamten
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32444041

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (500 mg tablet daily)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo (starch preparation)
Number of subjects: 144
Study: 33736674

Group type: EXPERIMENTAL
Intervention: Kai-Hou-Jian spray (children’s type)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo sprays
Number of subjects: 240
Study: 32600336

Group type: EXPERIMENTAL
Intervention: Cooling therapy initiated before reperfusion
Number of subjects: 77

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Cooling therapy and standard of care (pooled cohort)
Number of subjects: 77
Study: 35897081

Group type: EXPERIMENTAL
Intervention: MMPR plus sub‐dissociative ketamine infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: MMPR
Number of subjects: 0
Study: 32461050

Group type: EXPERIMENTAL
Intervention: Eccentrically biased flywheel leg-curl training (n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional flywheel leg-curl training (n=10)
Number of subjects: 20
Study: 34787719

Group type: EXPERIMENTAL
Intervention: Mtwo rotary files (group I)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ProTaper Universal rotary files (group II)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: F6 SkyTaper rotary files (group III)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no preparation and filling)
Number of subjects: 60
Study: 33216360

Group type: EXPERIMENTAL
Intervention: Low dose of drug
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High dose of drug
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35264408

Group type: COMPARATOR
Intervention: Antibiotic prophylaxis
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Methenamine hippurate
Number of subjects: 240
Study: 34750735

Group type: EXPERIMENTAL
Intervention: Cleaning and greening intervention
Number of subjects: 442
Study: 34644317

Group type: EXPERIMENTAL
Intervention: Azithromycin (100 mg for three days, given on four occasions at monthly intervals)
Number of subjects: 778
Study: 32703340

Group type: EXPERIMENTAL
Intervention: Low dose naltrexone 6mg daily
Number of subjects: 71
Study: 34198230

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Written Exposure Therapy (WET)
Number of subjects: 126
Study: 33883876

Group type: EXPERIMENTAL
Intervention: Vaginal administration of estradiol (E2) and dydrogesterone (DG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Oral administration of estradiol (E2) and dydrogesterone (DG)
Number of subjects: 20
Study: 32507436

Group type: EXPERIMENTAL
Intervention: Euiiyin-tang
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 36335914

Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg twice daily (2.5 mg twice daily for patients ≥80 years or weight ≤60 kg)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Warfarin (dose-adjusted)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg twice daily
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Apixaban pharmacokinetics
Number of subjects: 154
Study: 34715057

Group type: EXPERIMENTAL
Intervention: Infliximab (10 mg/kg over 2 hours without premedication)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Second IVIG (2 g/kg over 8-12 hours)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 105

Group type: COMPARATOR
Intervention: Second IVIG
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: IVIG (as either first or second treatment)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: IVIG
Number of subjects: 105
Study: 36253609

Group type: EXPERIMENTAL
Intervention: 3BNC117 + romidepsin
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 3BNC117
Number of subjects: 55

Group type: COMPARATOR
Intervention: ART only
Number of subjects: 55
Study: 32607917

Group type: EXPERIMENTAL
Intervention: Relationship education and HIV prevention program for male couples
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Higher rurality
Number of subjects: 430
Study: 33049118

Group type: EXPERIMENTAL
Intervention: Rd continuous (lenalidomide + low-dose dexamethasone)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Rd18 (fixed-duration lenalidomide + low-dose dexamethasone for 18 cycles)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Rd continuous
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Rd18
Number of subjects: 208

Group type: COMPARATOR
Intervention: MPT
Number of subjects: 208
Study: 35473439

Group type: EXPERIMENTAL
Intervention: Twice-daily dosing of deferasirox
Number of subjects: 41

Group type: COMPARATOR
Intervention: Once-daily dosing of deferasirox
Number of subjects: 41
Study: 34626921

Group type: EXPERIMENTAL
Intervention: Digital educational material + additional virtual interactive epilepsy session
Number of subjects: 130

Group type: COMPARATOR
Intervention: Digital educational material alone
Number of subjects: 130
Study: 32216086

Group type: EXPERIMENTAL
Intervention: Cefprozil (7-day course)
Number of subjects: 0
Study: 34119470

Group type: EXPERIMENTAL
Intervention: High-dose intravenous iron therapy
Number of subjects: 2141

Group type: COMPARATOR
Intervention: Low-dose intravenous iron therapy
Number of subjects: 2141
Study: 32379659

Group type: EXPERIMENTAL
Intervention: Kinesio taping and lifestyle changes
Number of subjects: 2

Group type: COMPARATOR
Intervention: Lifestyle changes
Number of subjects: 2
Study: 32358947

Group type: EXPERIMENTAL
Intervention: Intervention evaluations addressing cultural barriers and socio-economic conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Media and peer information sources
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cultural and gender norms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Education level and socio-economic status
Number of subjects: 0
Study: 35438782

Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg daily (cohort 1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg daily + Paclitaxel 80 mg/m2 on days 1, 8, and 15 of each 28-day cycle (cohort 2)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg daily + Paclitaxel 80 mg/m2 (cohort 2)
Number of subjects: 36
Study: 32427603

Group type: EXPERIMENTAL
Intervention: Military Sexual Trauma (MST)
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Younger Veterans with MST
Number of subjects: 328

Group type: COMPARATOR
Intervention: Younger Veterans without MST
Number of subjects: 328
Study: 35147758

Group type: EXPERIMENTAL
Intervention: Cold therapy using Siriraj in-house-developed frozen gloves worn during chemotherapy administration.
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (no cold therapy).
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Cold therapy using frozen gloves.
Number of subjects: 79
Study: 32925651

Group type: EXPERIMENTAL
Intervention: Nepafenac punctal plug delivery system (N‐PPDS)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo punctal plug delivery system (p‐PPDS)
Number of subjects: 56
Study: 35914101

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 26

Group type: COMPARATOR
Intervention: Education
Number of subjects: 26
Study: 33322448

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study: 33844393

Group type: EXPERIMENTAL
Intervention: Fructose 35 g
Number of subjects: 30
Study: 35119463

Group type: EXPERIMENTAL
Intervention: Clinical Decision Support System (CDSS) used in intervention clinics
Number of subjects: 18578

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 18578
Study: 33754202

Group type: EXPERIMENTAL
Intervention: Nemolizumab 0.125 mg/kg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nemolizumab 0.5 mg/kg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nemolizumab 2.0 mg/kg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nalfurafine hydrochloride (open-label reference group)
Number of subjects: 100
Study: 32054508

Group type: EXPERIMENTAL
Intervention: Septoplasty (surgery to straighten a deviation in the nasal septum) with or without reduction of the inferior nasal turbinate.
Number of subjects: 378

Group type: COMPARATOR
Intervention: Nasal saline spray followed by a fluorinated steroid spray daily for six months (medical management).
Number of subjects: 378
Study: 35380650

Group type: EXPERIMENTAL
Intervention: Hospital-based comprehensive medication reviews including postdischarge follow-up
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33271049

Group type: EXPERIMENTAL
Intervention: Cognitive processing therapy (CPT) for participants with at least 1 significant head injury (HI) during trauma.
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Cognitive processing therapy (CPT) for participants who denied head injuries but reported serious nonhead injuries (NHI).
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Cognitive processing therapy (CPT) for participants who denied any injury (NI).
Number of subjects: 306
Study: 32845553

Group type: EXPERIMENTAL
Intervention: Real-time feedback for self-monitoring via smartphone app for 5 weeks and 13 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Information about sedentary behavior (control group)
Number of subjects: 49
Study: 35387813

Group type: EXPERIMENTAL
Intervention: COPLA with SMT (n=200)
Number of subjects: 400

Group type: COMPARATOR
Intervention: SMT only (n=200)
Number of subjects: 400
Study: 33617937

Group type: EXPERIMENTAL
Intervention: SET2,3
Number of subjects: 575

Group type: COMPARATOR
Intervention: RCB
Number of subjects: 575
Study: 36336088

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg daily
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 34530859

Group type: EXPERIMENTAL
Intervention: Self-reported dietary measures in lifestyle intervention studies
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Simulation of treatment effects
Number of subjects: 380
Study: 32537688

Group type: EXPERIMENTAL
Intervention: rHuEPO (epoetin-β; mean dose 6000 IU per week)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 100
Study: 35548173

Group type: EXPERIMENTAL
Intervention: Saffron (100 mg/d)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 32331030

Group type: EXPERIMENTAL
Intervention: Deutetrabenazine 12 mg/day, titrating up to a maximum total daily dose of 48 mg/day based on dyskinesia control and tolerability.
Number of subjects: 343

Group type: COMPARATOR
Intervention: Placebo (in parent studies).
Number of subjects: 343
Study: 35354678

Group type: EXPERIMENTAL
Intervention: Graded motor imagery (GMI) along with conventional physiotherapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional physiotherapy (electrotherapy and exercises)
Number of subjects: 20
Study: 32278029

Group type: EXPERIMENTAL
Intervention: Tongguan Capsules (TGC) 4.5 g/d for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment for MI
Number of subjects: 0
Study: 35231791

Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 59
Study: 34605554

Group type: EXPERIMENTAL
Intervention: Intervention group received information regarding their risk of iron depletion and behaviors to mitigate this risk, including the opportunity to develop an action plan.
Number of subjects: 1533

Group type: COMPARATOR
Intervention: Control group answered questions regarding awareness of the risk of donation-related iron depletion and actions taken to address iron status.
Number of subjects: 1533

Group type: EXPERIMENTAL
Intervention: Intervention group with action planning paired with educational information.
Number of subjects: 1533
Study: 36117491

Group type: EXPERIMENTAL
Intervention: Behavior changing nursing intervention
Number of subjects: 222

Group type: COMPARATOR
Intervention: Routine postoperative nursing management
Number of subjects: 222
Study: 33657090

Group type: EXPERIMENTAL
Intervention: Ivermectin, DEC, and albendazole (IDA)
Number of subjects: 1919

Group type: COMPARATOR
Intervention: Diethylcarbamazine citrate and albendazole (DA)
Number of subjects: 1919
Study: 32947176

Group type: EXPERIMENTAL
Intervention: Danish school-based road safety educational program using testimonials
Number of subjects: 1007
Study: 33825016

Group type: EXPERIMENTAL
Intervention: Deep learning model (Xception) for surgical step classification
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Deep learning model (Xception) for surgical step classification including sub-steps
Number of subjects: 50
Study: 32776391

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (CCRT) alone
Number of subjects: 233

Group type: COMPARATOR
Intervention: Additional chemotherapy to concurrent chemoradiotherapy (CCRT)
Number of subjects: 233
Study: 33607459

Group type: EXPERIMENTAL
Intervention: Mental rehearsal
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (non-specific rehearsal)
Number of subjects: 62
Study: 35512918

Group type: EXPERIMENTAL
Intervention: Trial LAAO patients
Number of subjects: 1904

Group type: COMPARATOR
Intervention: Warfarin patients
Number of subjects: 1904